2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid
C20H22N4O5S — CID 175007458
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid
2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid (PubChem CID 175007458) has the molecular formula C20H22N4O5S and a molecular weight of 430.49 g/mol. Its IUPAC name is 2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid.
Molecular Properties
| Compound Name | 2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid |
|---|---|
| PubChem CID | 175007458 |
| Molecular Formula | C20H22N4O5S |
| Molecular Weight | 430.49 g/mol |
| Exact Mass | 430.13 |
| IUPAC Name | 2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]amino]pentanedioic acid |
| SMILES | Cc1nc2ccc(CN(C)c3ccc(NC(CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1 |
| InChI | InChI=1S/C20H22N4O5S/c1-11-21-14-4-3-12(9-13(14)19(27)22-11)10-24(2)17-7-6-16(30-17)23-15(20(28)29)5-8-18(25)26/h3-4,6-7,9,15,23H,5,8,10H2,1-2H3,(H,25,26)(H,28,29)(H,21,22,27) |
| InChIKey | ZWLUBWUNVPZNCQ-UHFFFAOYSA-N |
| XLogP | 2.66 |
| TPSA | 135.62 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.49 |
| LogP ≤ 5 | 2.66 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175007458 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.